PDCD1 and neoplasm: Using germ-free mice transplanted with fecal microbiota from anti-PD-1 responder or non-responder patients, it has been clearly demonstrated that addition of certain bacterial strains in the gut of mice leads to better anti-tumor response rates of anti-PD-1/PD-L1 therapy [99].